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Abstract
Ginseng root is used more often than other parts such as leaf stem although extracts from ginseng
leaf-stem also contain similar active ingredients with pharmacological functions. Ginseng's leaf-
stems are more readily available at a lower cost t\han its root. This article reviews the
pharmacological effects of ginseng leaf-stem on some diseases and adverse effects due to excessive
consumption. Ginseng leaf-stem extract contains numerous active ingredients, such as
ginsenosides, polysaccharides, triterpenoids, flavonoids, volatile oils, polyacetylenic alcohols,
peptides, amino acids and fatty acids. The extract contains larger amounts of the same active
ingredients than the root. These active ingredients produce multifaceted pharmacological effects
on the central nervous system, as well as on the cardiovascular, reproductive and metabolic
systems. Ginseng leaf-stem extract also has anti-fatigue, anti-hyperglycemic, anti-obesity, anti-
cancer, anti-oxidant and anti-aging properties. In normal use, ginseng leaf-stem extract is quite safe;
adverse effects occur only when it is over dosed or is of poor quality. Extracts from ginseng root
and leaf-stem have similar multifaceted pharmacological activities (for example central nervous and
cardiovascular systems). In terms of costs and source availability, however, ginseng leaf-stem has
advantages over its root. Further research will facilitate a wider use of ginseng leaf-stem.
Background
Ginseng is cultivated in China, Korea, Japan and Russia, as
well as in the United States and Canada. Ginseng is one of
the most well-known herbal medicines widely used in
East Asia as a tonic, restorative and anti-aging agent in tra-
ditional Chinese medicine [1-8]. Ginseng is a slow-grow-
ing, deciduous, perennial plant of the Araliaceae family
which includes Panax ginseng (Renshen, Chinese or Korean
ginseng), Panax japonicus (Japanese ginseng) and Panax
quinquefolius (Xiyangshen, American ginseng) [9]. Ginseng
is used as a dietary supplement in the United States [10].
In Chinese medicine practice, ginseng root is the most
commonly used part of the plant. It contains ginsenosides
as the major bioactive components known to have com-
plex and multiple pharmacological effects [2,11].
While ginseng leaf-stem was less studied [12], a recent
report indicates that American ginseng leaf contains simi-
lar pharmacologically active ingredients more abundantly
than ginseng root [13]. Panax ginseng leaf-stem is rich in
containing several ginsenosides. Therefore, this article
reviews the constituents and pharmacological profile of
ginseng leaf-stem, including its chemical components,
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biological activities, pharmacological properties and
adverse effects.
Bioactive constituents
Ginseng leaf-stem extract contains a number of important
bioactive constituents [14,15], namely ginsenosides,
polysaccharides, triterpenoids and flavonoids [16].
Among other constituents, ginsenosides exert main phar-
macological actions of ginseng root, leaf-stem and berry
[17]. More than 30 ginsenosides have been isolated and
identified [10] in Panax quinquefolius, Panax ginseng and
Panax japonicus [11,18-20]. Ginsenoside content in the
leaf of Panax quinquefolius is higher than in the root[21].
However, significant variations in content exist between
major ginsenosides in the leaf [13,22-24]. Re and Rd are
the major ginsenosides in the ginseng leaf [13,21]. Gin-
seng leaf-stem may be a valuable source for Re, Rd and
Rb2 [23].
Seasonal fluctuations, geographical differences and age
variations may affect the ginsenoside content in ginseng
leaf. According to a study using solid phase extraction and
high performance liquid chromatography (HPLC) on
American ginseng leaf and [25], Rh1, Rg2, 20(R)-Rg2 and
Rg3 accounted for 4.71% in leaf and 5.35% in berry of
American. A RP-HPLC (Reversed-Phase High Performance
Liquid Chromatography) study on Rh2 saponin of Amer-
ican ginseng leaf studied the transform ratio of 20(S)-gin-
senoside Rh2 [26]. Using HPLC with UV detection at 203
nm, Shi et al. found that the seven major ginsenosides
(Rg1, Re, Rb1, Rc, Rb2, Rb3 and Rd) were present in vari-
ous parts of Chinese ginseng of various ages [27]. These
results also indicate that ginsenoside content is higher in
the leaf and root hair but lower in the stem than that in
other parts of the plant and that the total content of gin-
senosides in the leaf decreases with age [25-27].
Yan et al. developed a simple and reliable liquid chroma-
tography/electron spray ionization mass spectrometry
(LC-ESI/MS) assay to detect Chinese ginseng leaf-stem
saponin (GLSS) in methanol and rat plasma and to con-
struct the fingerprints of GLSS reference substances and
plasma samples. Thirty-one compounds were detected in
GLSS, ten of which were identified in the fingerprints of
reference substances and the spiked plasma sample.
Twelve compounds in GLSS, including C7, C8, C14, C15,
C18, Re, C24, Rb(1), Rc, Rb(2), Rb(3) and Rd were easily
absorbed and might be the metabolites of GLSS [28].
Moreover, two new compounds were separated from
Panax ginseng leaf [29].
Pharmacological functions
Ginseng leaf-stem extracts exhibit multifaceted pharmaco-
logical actions in the central nervous system (CNS), cardi-
ovascular system, growth-metabolism system and
immune system [30-32] (Table 1). Ginseng leaf-stem
extracts also possess anti-fatigue, anti-hyperglycemic, anti-
obesity, anti-cancer, anti-oxidant and anti-aging activities
as described below.
Effects on the CNS
An early study revealed that ginseng leaf extract caused
CNS depression and neuroleptic effects in mice [30-32].
The extract-induced CNS depression was observed along
with a reduction of spontaneous and exploratory move-
ments and the potentiation of hypnotic actions of hexo-
barbital. Analgesic and anticonvulsant activities were also
confirmed in this study. Moreover, ginseng leaf extract
inhibited conditioned avoidance response in the pole
climbing test.
Effects of saponins from Chinese ginseng leaf-stem on
memory, learning and biogenic monoamines of the brain
were also examined in rats [33]. Results showed that gin-
seng root saponins improved learning and memory in
normal male rats, while the effects of ginseng leaf-stem
saponins on anti-electroconvulsive shock-induced
impairment of memory consolidation were more intense.
Both leaf-stem and root saponins raised the levels of bio-
genic monoamines significantly in the brains of normal
rats. In another study, the effects of ginseng leaf-stem
saponins on learning and memory of one-way avoidance
were evaluated in shuttle-box rats [34]. The data indicated
that ginseng leaf-stem saponins facilitated the acquisition
of learning and memory and ameliorated scopolamine
and cycloheximide amnesia. Effects of ginseng leaf extract
on the CNS were also examined in various species of gin-
seng [35]. For example, Siberian ginseng leaf extract was
found to have anti-fatigue, anti-stress and anti-depressive
effects. An In vivo study revealed that a Chinese herbal for-
mula consisting of ginseng leaf, namely Jiannaoning,
improved memory function in rats with cerebral ischemia
[36] and that Jiannaoning  regulated the levels of inter-
leukin-2, interleukin-6 and neuropeptide Y in rat brain.
Moreover, ginsenosides from ginseng leaf-stem affected
the level of glucocorticoid receptor (GR) in brain cytosol
in heat-damaged rats [37]. Binding activities of GR in
brain, lung and liver cytosols and the expression levels of
GR mRNA in brain and liver cytosols were all higher in the
ginsenosides-treated groups than the untreated control
group. Ginsenosides reduced GR binding activity in vis-
cera which may have induced the expression of GR
mRNA. Another study [38], however, indicated that
extract from the aboveground part of Chinese ginseng
(including ginseng leaf-stem) had a weaker effect or no
effect on the animal behavior compared to ginseng root.
Effects on cardiovascular system
Ginseng leaf extracts had preservative effects on the car-
diac and vascular systems and prevented myocardialChinese Medicine 2009, 4:20 http://www.cmjournal.org/content/4/1/20
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ischemia in animal experiments [39]. In anaesthetized
open-chest dogs treated with American ginseng leaf
extract, the myocardial infarct size, activity of serum crea-
tine kinase (CK), lactate dehydrogenase (LDH), the con-
tents of serum free fatty acid (FFA) and lactoperoxidase
(LPO) significantly decreased, whereas the activity of
serum superoxide dismutase (SOD) and Gtutathione per-
oxidase (GSH-Px) significantly increased. At the same
time, myocardial blood flow was increased and coronary
vascular resistance was decreased. The results indicate that
the ginseng leaf extract protected against myocardial
ischemia by modifying metabolic dysfunction of FFA,
inhibiting oxygen free radical-mediated peroxidation of
membrane lipids, enhancing endogenous antioxidase
activity and increasing myocardial blood supply. Another
study [40] confirmed that ginseng leaf-stem extract pro-
tects against acute myocardial infarction (AMI) in rats by
promoting angiogenesis in the infracted or ischemic area
of myocardium.
A previous study demonstrated that Chinese ginseng leaf-
stem extracts had beneficial effects on the preservation of
cardiac and coronary vascular functions after cold storage
for 12 hours in isolated rat hearts. The extracts increased
coronary artery dilation and coronary flow in response to
an endothelial-dependent vasodilator (ACh), protected
the coronary endothelium, prevented coronary vascular
dysfunction induced by reperfusion injury after hypother-
mic heart preservation and attenuated reperfusion dam-
age of vascular smooth muscle cells [41].
Furthermore, American ginseng leaf-stem saponins were
reported to antagonize the effects of norepinephrine
(NE), potassium chloride and calcium chloride on the iso-
lated aortic strips of rabbits [42]. The saponins inhibited
Table 1: Major pharmacological effects of ginseng leaf-stem extracts
Pharmacological effects Dose Subjects References
Central nervous system
CNS-depression effects -- Mice [30-32]
Anti-electroconvulsive shock 50 mg/kg × 7 days Rats [33]
Improving memory 11.25 g/kg Jiannaoning Rats [36]
Cardiovascular system
Protecting cardiac cell 20 mg/kg iv; 54,27,13.5 mg/kg Dogs; rats [39,40]
Preventing coronary vascular dysfunction 120 mg/kg Rats [41]
Antagonizing (NE, KCl, CaCl2) effects 0.03-3 mg/min Rabbits; guinea pigs [42,43]
Anti-CHD effects -- Patients [44]
Effects on ANP gene expression 50 mg/kg × 7 d Rats [45,46]
Effects on Growth and metabolism
Increasing body weight -- Young mice and rats [32]
Effects on lipid metabolism -- Hyperlipidemic mice [47]
Regulating lipid metabolism 60 mg/kg Rabbits [48]
Anti-hyperglycemic effects
Anti-diabetic effects -- Diabetic patients [49]
Anti-hyperglycemic effects -- Mice, rats [58]
Lowering blood glucose 150 mg/kg × 12 d ob/ob mice [21]
Increasing blood insulin -- Mice; rats [60]
Hypoglycemic activities 200 mg/kg × 12 d ob/ob mice [61]
Anti-obesity activities
Decreasing body weight 150 mg/kg × 12 d ob/ob mice [21,61]
Anti-cancer effects
Anti-prostate, bladder and renal cancer -- Patients [63]
Killing cancer cells via at least 5 pathways -- Normal and cancer cells [64]
Reducing apoptotic cell number 60-140 mg/kg Mouse cells [65]
Anti-oxidant activity
Suppressing antioxidant enzyme activity 40-200 mg/kg Diabetic rats [69]
Antioxidant property in cardiac cells 0.25-1 mg/ml Rat cultured cardiac cells [8]
Restoring free radical-damaged cells 30 μg/ml (Rb1,2,3) Cultured myocardiomyocytes [72]
Other pharmacological effects
Anti-fatigue 100/200 mg/kg Rats [73]
Anti-ulcer 100 mg/kg Mice [6]
Anti-diuretic -- Rats [31]
Anti-aging -- Patients [74]
Anti-foot-and-mouth disease 10 μg* +oil emulsion Mice [76]Chinese Medicine 2009, 4:20 http://www.cmjournal.org/content/4/1/20
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intracellular and extracellular Ca2+-dependent contrac-
tions induced by NE in rabbit aortic strips. Another study
revealed that American ginseng saponins inhibited the
contractility of guinea pig papillary muscle [43]. A rand-
omized controlled trial with double blinding indicated
that Shenshao Tongguan Piana, a proprietary Chinese med-
icine formula containing ginseng leaf-stem extract, effec-
tively treated angina pectoris in coronary heart disease
(CHD) with effective rates of 94.7% and 67.0% in the
treatment and control groups respectively [44].
Several studies revealed that ginseng leaf-stem extract
affected atrial natriuretic peptide (ANP) gene expression
in older rats [45,46] and that both ginseng leaf-stem and
root extracts increased the ANP mRNA in rats. An in vivo
study on American ginseng leaf extracts showed that the
expression of vascular endothelial growth factor (VEGF)
and mean micro-vessel density were higher in the ginseng
leaf saponin groups than in the vehicle model group and
that the expression of basic fibroblast growth factor
(bFGF) was higher in the ginseng leaf saponin groups
than in the vehicle model group [40], suggesting that gin-
seng leaf-stem extracts may protect myocardium from
ischemic injury in rats with AMI by up-regulating VEGF
and bFGF in myocardial cells thereby inducing angiogen-
esis.
Effects on growth and intermediary metabolism
Ginsenosides from Chinese ginseng leaf-stem signifi-
cantly increased the protein and RNA contents of muscles
and liver in rats and that ginsenosides accelerated the
growth of young pigs. It was suggested that ginsenosides
may have direct influence on RNA and protein synthesis
[32].
Ginsenosides from ginseng leaf-stem coupled with aero-
bic exercise lowered serum lipid, regulated lipid metabo-
lism, promoted antioxidation and enhanced immune
activity [47]. Oral administration of ginsenosides
extracted from ginseng leaf-stem significantly inhibited
the rise of total lipid, cholesterol and triglyceride in rab-
bits [48].
Anti-hyperglycemic effects
One third of diabetic patients use dietary supplements or
alternative medicines [49]. Previous studies indicated that
ginseng is an important alternative medicine to treat dia-
betes and both Chinese and American ginseng roots had
anti-hyperglycemic effect [50-53]. Ginseng berry extract
reduced hyperglycemia and body weight in C57BL/6J ob/
ob mice [54,55] and C57BL/Ks db/db mice [56]. Ginseng
leaf-stem extracts also had this anti-diabetic effect
[21,57,58]. Ginseng leaf and root extracts increased the
basal content and glucose-dependent secretion of insulin
in blood [59].
Active ingredients and hypoglycemic properties of Ameri-
can ginseng leaf were examined with high performance
liquid chromatography (HPLC) in diabetic ob/ob  mice
[21]. The results indicated that American ginseng leaf
extract significantly reduced blood glucose levels. Intra-
peritoneal glucose tolerance test showed that the leaf
extract significantly improved glucose disposal. Thus,
American ginseng leaf extract, with its high ginsenoside
yield, may be an inexpensive alternative to the root for
diabetic treatment. Similar anti-hyperglycemic activity
was observed in a study on total ginsenosides of Chinese
ginseng leaf-stem [60].
Anti-obesity effect
Obesity is a serious medical disorder that may cause a
myriad of health problems, such as heart disease, hyper-
tension and adult-onset diabetes. Berry, root and leaf
extracts of American and Chinese ginseng as well as total
ginsenosides of Chinese ginseng leaf-stem had anti-obes-
ity activities in animals and that American ginseng leaf
extract significantly reduced body weight in adult ob/ob
mice [21,54,56,60,61].
Anti-cancer effect
Anti-cancer effect of ginseng leaf-stem is an important
pharmacological function. Anti-cancer effects of Chinese
ginseng leaf extract were found after co-administration of
acidic polysaccharide from Chinese ginseng leaf enhanced
therapeutic effects and reduced hematopoietic complica-
tions induced by systemic chemotherapy or radiation
therapy [62]. Acidic polysaccharide may be a novel and
potent immunotropic agent to improve cellular immunity
and an anti-cancer drug to treat urological cancer patients.
Extract of Indian ginseng leaf (Ashwagandha) had anti-can-
cer activities [63]. Total saponins from Panax ginseng leaf-
stem protected against cyclophosphamide (a commonly
used anti-cancer compound)-induced genotoxicity and
apopotosis in bone marrow cells and peripheral lym-
phocytes in mice [64]. Thus, ginseng leaf extracts can be a
new source for anti-cancer drugs.
Kitts et al. also confirmed that ginsenoside Rh2 extracted
from American ginseng leaf induced cytotoxity in cultured
leukemia THP-1 cells [65]. Flow cytometry of cells stained
with annexin V-fluorescein isothiocyanate and propidium
iodide showed that the Rh2 from ginseng leaf significantly
increased apoptosis at a concentration that inhibited cell
viability by 50% (LC50). Ginsenoside (Rh2) may be the
active ingredient for anti-cancer activity in ginseng leaf
[65].
Anti-oxidant activities
Extracts from American ginseng root and berry possess
antioxidant properties [5,13,35,66,67] and so does gin-
seng leaf extract. In streptozotocin-induced diabetic rats,Chinese Medicine 2009, 4:20 http://www.cmjournal.org/content/4/1/20
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oral administration of wild ginseng leaf extract (WGLE)
effectively suppressed lipid peroxidationin diabetic rats
[68]. Similar antioxidant activities were observed in culti-
vated and wild Korean ginseng leaf extracts [69]. It was
confirmed that water, methanol and ethanol extracts form
freeze-dried leaves of wild ginseng exhibited scavenging
activities towards DPPH (2,2-diphenyl-2-picrylhydrazyl
hydrate), superoxide anion and hydroxyl radicals. Among
various solvent used to extract wild ginseng leaves, etha-
nol yielded the highest DPPH, hydroxyl radical scaveng-
ing and ferrous ion chelating activity [70].
Not surprisingly, the saponin extracted from American
ginseng leaf-stem (0.25-1 mg/ml) also demonstrated anti-
oxidant properties in cultured rat cardiomyocytes [5].
Moreover, Rb1, Rb2 and Rb3 extracted from Panax ginseng
leaf-stem restored the action potentials of free radical
damaged cells [71].
Other effects
Anti-fatigue effect
Chinese ginseng leaf-stem extract had anti-fatigue effects.
In rats, orally administered saponins extracted from Chi-
nese ginseng leaf-stem significantly prolonged swimming
time, inhibited the increase of blood lactic acid and
reduced liver and rectus femurs muscle glycogen. Ginseng
leaf-stem extract also facilitated the synthesis of protein
and expression of mRNA in liver and muscle tissues [72].
Anti-ulcer effect
Panax ginseng root is used in Chinese medicine to treat
gastrointestinal disorders. Research showed that the crude
polysaccharide fraction from ginseng leaf exhibited
potent anti-ulcer activity against acute gastric lesions in
mice [3].
Anti-diuretic effect
Anti-diuresis was another pharmacological property of
ginsenoside from Panax ginseng leaf-stem. Total ginseno-
sides from the leaf-stem helped retain water and Na+,
increased K+ excretion and reduced the ratio of urinary
Na+/K+ in rats [73].
Anti-aging effects
A clinical trial showed that Tongbu No.1, a proprietary
Chinese medicine formula containing ginseng leaf,
improved various some symptoms related to aging,
improved immune and endocrinal functions, scavenged
free radicals and adjusted intestinal flora [74].
Inductive differentiation effect
Ginsenosides from Panax ginseng leaf-stem induced the
differentiation of all types of acute nonlymphocytic leuke-
mia cells in primary culture [75].
Saponins, as well as the combination of saponins and oil,
significantly enhanced the immune response in mice to
vaccination against foot-and-mouth disease (FMDV) [76].
Co-administered with the saponins, FMDV antigen
induced a significantly higher IgG response than FMDV
antigen used alone.
Potential adverse effects
Both animal experiments and clinical trials have shown
that normal use of ginseng is safe [50,76]. Asian ginseng
is classified as a generally safe herb along with feverfew,
garlic, ginkgo, saw palmetto, St. John's wort and valerian
[77]. Ginseng, including ginseng root and leaf-stem, may
exhibit minor adverse effects [78]. A systematic review of
adverse effects of ginseng suggested that Panax ginseng
monopreparations are rarely associated with adverse
events or drug interactions [79]. The adverse effects in
clinical trials or toxic effects in animal experiments were
attributed to improper use or poor quality of ginseng [80-
83].
Acute toxic effects
Toxicity of ginsenosides from Panax ginseng leaf-stem was
determined in mice. When mice were given ginsenosides
per oral, no death occurred [31,32]. Another report [84]
indicated that the LD50 values of crude saponin fraction
and saponins of ginseng leaves were 381 mg/kg and 299
mg/kg respectively.
Subacute toxic effects
Ginseng leaf-stem extracts did not affect the number of
erythrocytes, leukocytes, thrombocytes, the amount of
hemoglobin or renal function in subacute toxic experi-
ments in rats [32]. Body weight, food consumption and
liver weight of rats increased [32]. Brain, heart, lungs,
liver, spleen, kidneys, stomach, testes and ovaries were
normal on gross examination and histopathological
study. These findings suggested that high quality ginseng
leaf-stem and its preparations were safe in normal use.
Limitations of current research
(1) Most studies on the constituents of ginseng leaf-stem
extract have been qualitative. Quantitative studies will be
required. (2) Quality control of ginseng leaf-stem prepa-
rations has not been adequately assured. (3) Few rand-
omized, double-blind, placebo-controlled clinical trials
on ginseng leaf-stem extracts are available. Further labora-
tory and clinical studies are warranted for wider pharma-
ceutical use of ginseng leaf-stem.
Conclusion
Extracts from ginseng root and leaf-stem have similar
multifaceted pharmacological activities (e.g. CNS and car-
diovascular system). In terms of costs and source availa-
bility, ginseng leaf-stem has advantages over its root.Chinese Medicine 2009, 4:20 http://www.cmjournal.org/content/4/1/20
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Further research will facilitate a wider use of ginseng leaf-
stem.
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